Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond

EBioMedicine. 2018 Feb:28:31-42. doi: 10.1016/j.ebiom.2018.01.025. Epub 2018 Feb 2.

Abstract

Ischemia-reperfusion injury (IRI) during renal transplantation often initiates non-specific inflammatory responses that can result in the loss of kidney graft viability. However, the long-term consequence of IRI on renal grafts survival is uncertain. Here we review clinical evidence and laboratory studies, and elucidate the association between early IRI and later graft loss. Our critical analysis of previous publications indicates that early IRI does contribute to later graft loss through reduction of renal functional mass, graft vascular injury, and chronic hypoxia, as well as subsequent fibrosis. IRI is also known to induce kidney allograft dysfunction and acute rejection, reducing graft survival. Therefore, attempts have been made to substitute traditional preserving solutions with novel agents, yielding promising results.

Keywords: Acute rejection; Graft survival; Ischemia-reperfusion; Renal transplantation; Th cells: T helper cells.

Publication types

  • Review

MeSH terms

  • Animals
  • Graft Survival*
  • Humans
  • Kidney Transplantation*
  • Models, Biological
  • Reperfusion Injury / therapy*